Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22204724

Incorporation of bevacizumab in the primary treatment of ovarian cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2011 Dec 29
First author
Burger RA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Cancer. 2012 Jan 24;12(2):83. doi: 10.1038/nrc3213.
    note
    Source null
    related pmid
    22270952
    relationship
    Comment in
  2. citation
    N Engl J Med. 2012 Mar 29;366(13):1256; author reply 1257-8. doi: 10.1056/NEJMc1201044.
    note
    Source null
    related pmid
    22455428
    relationship
    Comment in
  3. citation
    N Engl J Med. 2012 Mar 29;366(13):1256-7; author reply 1257-8. doi: 10.1056/NEJMc1201044.
    note
    Source null
    related pmid
    22455429
    relationship
    Comment in

Authors and identifiers

  1. name
    Burger RA
    type
    Author
  2. name
    Brady MF
    type
    Author
  3. name
    Bookman MA
    type
    Author
  4. name
    Fleming GF
    type
    Author
  5. name
    Monk BJ
    type
    Author
  6. name
    Huang H
    type
    Author
  7. name
    Mannel RS
    type
    Author
  8. name
    Homesley HD
    type
    Author
  9. name
    Fowler J
    type
    Author
  10. name
    Greer BE
    type
    Author
  11. name
    Boente M
    type
    Author
  12. name
    Birrer MJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Burger RA
    type
    Author
  2. name
    Brady MF
    type
    Author
  3. name
    Bookman MA
    type
    Author
  4. name
    Fleming GF
    type
    Author
  5. name
    Monk BJ
    type
    Author
  6. name
    Huang H
    type
    Author
  7. name
    Mannel RS
    type
    Author
  8. name
    Homesley HD
    type
    Author
  9. name
    Fowler J
    type
    Author
  10. name
    Greer BE
    type
    Author
  11. name
    Boente M
    type
    Author
  12. name
    Birrer MJ
    type
    Author
bibliography ids
  1. nci-bib-b14c4570ef1fda219bf8973f
book metadata
content sha256
693ddd55f35e1319d593b0bfe097f65fdacf81bc37adc4f823ff20dc267ad36e
document type
citation
dois
  1. 10.1056/NEJMoa1104390
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:22204724
immutable id
pubmed:22204724@693ddd55f35e1319d593b0bfe097f65fdacf81bc37adc4f823ff20dc267ad36e
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
26
name
The New England journal of medicine
nlm unique id
0255562
pages
2473-83
volume
365
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Cancer. 2012 Jan 24;12(2):83. doi: 10.1038/nrc3213.
    note
    Source null
    related pmid
    22270952
    relationship
    Comment in
  2. citation
    N Engl J Med. 2012 Mar 29;366(13):1256; author reply 1257-8. doi: 10.1056/NEJMc1201044.
    note
    Source null
    related pmid
    22455428
    relationship
    Comment in
  3. citation
    N Engl J Med. 2012 Mar 29;366(13):1256-7; author reply 1257-8. doi: 10.1056/NEJMc1201044.
    note
    Source null
    related pmid
    22455429
    relationship
    Comment in
outcomes validated
false
pmid
22204724
provenance
batch id
b6284687e167e7da9556
provider
NCBI PubMed ESummary
record sha256
13e7323942233cb807b9d9710378e3b6e63bf507da75e9d350b8c9941c13556d
response sha256
64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
retrieved at
2026-09-09T23:46:45.216259+00:00
publication date
display
2011 Dec 29
precision
day
year
2011
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22204724/
title
Incorporation of bevacizumab in the primary treatment of ovarian cancer.

Preserved source evidence · Not medical advice